JNJ

J&J's MedTech unit pauses all cases of the Varipulse PFA system as part of an external evaluation. Stock dips.

Johnson & Johnson (JNJ) reachead $146.18 at the closing of the latest trading day, reflecting a +1.75% change compared to...

Median overall survival improvement expected to exceed one year First and only regimen with a survival benefit over current standard...

If history is any teacher, the best thing you can do with your money is buy dividend stocks.

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key...

The latest trading day saw Johnson & Johnson (JNJ) settling at $144.62, representing a +0.89% change from its previous close.

Those who own the stock may stay invested for some time as J&J looks optimistic about a better performance in...

Johnson & Johnson JNJ, the iconic healthcare giant known for its stable dividends and defensive appeal, has entered a bearish...

Johnson & Johnson announces a global licensing deal with Kaken for the latter's eczema candidate, KP-723, to further strengthen its...

Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what...